On Tuesday, LifeStance Health Group Inc (NASDAQ: LFST) opened lower -0.49% from the last session, before settling in for the closing price of $6.16. Price fluctuations for LFST have ranged from $4.64 to $8.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 44.91% over the last five years. Company’s average yearly earnings per share was noted 42.63% at the time writing. With a float of $115.87 million, this company’s outstanding shares have now reached $382.74 million.
The firm has a total of 10218 workers. Let’s measure their productivity. In terms of profitability, gross margin is 28.88%, operating margin of -2.49%, and the pretax margin is -4.61%.
LifeStance Health Group Inc (LFST) Insider Activity
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of LifeStance Health Group Inc is 69.87%, while institutional ownership is 35.02%. The most recent insider transaction that took place on Apr 09 ’25, was worth 34,349. In this transaction Director of this company sold 4,900 shares at a rate of $7.01, taking the stock ownership to the 1,421,990 shares. Before that another transaction happened on Apr 08 ’25, when Company’s Director sold 14 for $7.00, making the entire transaction worth $98. This insider now owns 1,424,440 shares in total.
LifeStance Health Group Inc (LFST) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.63% per share during the next fiscal year.
LifeStance Health Group Inc (NASDAQ: LFST) Trading Performance Indicators
Check out the current performance indicators for LifeStance Health Group Inc (LFST). In the past quarter, the stock posted a quick ratio of 1.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.88. Likewise, its price to free cash flow for the trailing twelve months is 27.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.01 in one year’s time.
Technical Analysis of LifeStance Health Group Inc (LFST)
Analysing the last 5-days average volume posted by the [LifeStance Health Group Inc, LFST], we can find that recorded value of 1.14 million was lower than the volume posted last year of 1.65 million. As of the previous 9 days, the stock’s Stochastic %D was 24.15%. Additionally, its Average True Range was 0.29.
During the past 100 days, LifeStance Health Group Inc’s (LFST) raw stochastic average was set at 4.42%, which indicates a significant decrease from 10.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.46% in the past 14 days, which was higher than the 34.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.16, while its 200-day Moving Average is $6.92. Now, the first resistance to watch is $6.22. This is followed by the second major resistance level at $6.32. The third major resistance level sits at $6.41. If the price goes on to break the first support level at $6.03, it is likely to go to the next support level at $5.94. Should the price break the second support level, the third support level stands at $5.84.
LifeStance Health Group Inc (NASDAQ: LFST) Key Stats
There are currently 384,550K shares outstanding in the company with a market cap of 2.36 billion. Presently, the company’s annual sales total 1,251 M according to its annual income of -57,440 K. Last quarter, the company’s sales amounted to 325,480 K and its income totaled -7,110 K.
